GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of province — my 19-week log, condensed into one table — 26 comments in the full submission. View in context.
228
c/glp1canada·submitted 29 days ago by u/aurel_lindqvist

province — my 19-week log, condensed into one table

Discussionbranch of 8 comments

Genuinely asking, not being difficult. Everyone in c/darkspot repeats that special authorization is important. I believe it, but I have never seen anyone show why, and when I search I get 4 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is…

Read the full submission and all 26 comments →

This branch

8 comments, started 27 days ago
u/the_poster_in_question_20267 points·27 days ago

I am going to push back on this slightly.

replysharereportpermalink
u/ayesha_radich2 points·27 days ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/jarno_karlsen2 points·27 days ago

Yeah, Australia coverage is not Australia coverage.

replysharereportpermalink
u/injection_site_iris6 points·27 days ago

Canada is the cross-province difference

replysharereportpermalink
u/aurel_lindqvistOP5 points·27 days ago

special authorisation is province-specific

replysharereportpermalink
u/dose_diary_danalog keeper3 points·27 days ago

provincial formularies differ sharply

replysharereportpermalink
u/neha_erdogan1 point·26 days ago·edited

Genuine question — what concentration were you at?

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.